Point72 Hong Kong’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-48,764
| Closed | -$3.45M | – | 470 |
|
|
2025
Q1 | $3.45M | Buy |
+48,764
| New | +$3.45M | 0.22% | 104 |
|
|
2024
Q2 | – | Sell |
-9,411
| Closed | -$822K | – | 462 |
|
|
2024
Q1 | $822K | Buy |
+9,411
| New | +$822K | 0.04% | 288 |
|
|
2022
Q2 | – | Sell |
-7,836
| Closed | -$604K | – | 1474 |
|
|
2022
Q1 | $604K | Buy |
7,836
+2,767
| +55% | +$213K | 0.02% | 280 |
|
|
2021
Q4 | $448K | Buy |
+5,069
| New | +$448K | 0.02% | 308 |
|
|
2021
Q2 | – | Sell |
-8,466
| Closed | -$639K | – | 1380 |
|
|
2021
Q1 | $639K | Buy |
+8,466
| New | +$639K | 0.02% | 350 |
|
|
2020
Q2 | – | Sell |
-230
| Closed | -$19K | – | 1144 |
|
|
2020
Q1 | $19K | Buy |
+230
| New | +$19K | 0.01% | 559 |
|
|
2019
Q3 | – | Sell |
-1,156
| Closed | -$99K | – | 1019 |
|
|
2019
Q2 | $99K | Sell |
1,156
-70
| -6% | -$6K | 0.03% | 494 |
|
|
2019
Q1 | $109K | Buy |
1,226
+1,078
| +728% | +$95.8K | 0.04% | 343 |
|
|
2018
Q4 | $13K | Sell |
148
-903
| -86% | -$79.3K | 0.01% | 502 |
|
|
2018
Q3 | $102K | Buy |
1,051
+1,022
| +3,524% | +$99.2K | 0.03% | 330 |
|
|
2018
Q2 | $3K | Buy |
+29
| New | +$3K | ﹤0.01% | 735 |
|
|
2018
Q1 | – | Sell |
-1,400
| Closed | -$125K | – | 905 |
|
|
2017
Q4 | $125K | Buy |
+1,400
| New | +$125K | 0.1% | 88 |
|
|
2017
Q3 | – | Sell |
-560
| Closed | -$51K | – | 812 |
|
|
2017
Q2 | $51K | Buy |
+560
| New | +$51K | 0.05% | 216 |
|
|
2016
Q4 | – | Sell |
-14,210
| Closed | -$1.32M | – | 865 |
|
|
2016
Q3 | $1.32M | Buy |
+14,210
| New | +$1.32M | 0.72% | 27 |
|
|
2016
Q2 | – | Sell |
-10,051
| Closed | -$829K | – | 523 |
|
|
2016
Q1 | $829K | Buy |
+10,051
| New | +$829K | 1.62% | 12 |
|
|
2015
Q4 | – | Sell |
-294
| Closed | -$31K | – | 497 |
|
|
2015
Q3 | $31K | Buy |
+294
| New | +$31K | 0.05% | 89 |
|
|
2015
Q1 | – | Sell |
-421
| Closed | -$38K | – | 281 |
|
|
2014
Q4 | $38K | Buy |
+421
| New | +$38K | 0.04% | 410 |
|